Title : Phase 2 study of afatinib among patients with recurrent and/or metastatic esophageal squamous cell carcinoma.

Pub. Date : 2020 Oct 15

PMID : 32749686






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The results of the current study have highlighted the clinical value of EGFR and TP53 as predictive biomarkers of platinum-resistant recurrent and/or metastatic ESCC for afatinib sensitivity. Platinum tumor protein p53 Homo sapiens